Equillium Inc

NASDAQ:EQ  
6.01
+0.05 (+0.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Equillium Inc Stock, NASDAQ:EQ

2223 Avenida de la Playa, Suite 105, La Jolla, California 92037
United States of America
Phone: +1.858.412.5302
Number of Employees: 31
http://www.equilliumbio.com

Description

Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.